BKBassam M. Kanber

Bassam M. Kanber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bassam M. Kanber has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Interpretable refinement of medical foundation-model segmentation via visual thinking states and uncertainty gating

    by Bassam M. Kanber, Shuiping Gou, Bo Liu, Naglaa F. Noaman, Magd Mukred, Ahmad Al Smadi


  • Open Access

    Advancing Oncology Diagnostics: AI-Enabled Early Detection of Lung Cancer Through Hybrid Histological Image Analysis

    by Naglaa F. Noaman, Bassam M. Kanber, Ahmad Al Smadi, Licheng Jiao, Mutasem K. Alsmadi

    Against the backdrop of the pervasive global challenge of cancer, with particular emphasis on lung cancer (LC), this study centers its investigation on the critical realm of early detection leveraging artificial intelligence (AI) within the domain of histological image analysis. Through the fusion of DenseNet201 with color histogram techniques, a novel hybrid feature set emerges, engineered to elevate classification accuracy. The comprehensive evaluation encompasses eight diverse machine learning (ML) algorithms, spanning from K-Nearest Neighbors (KNN) to Support Vector Machines (SVM), including notable contenders such as LightGBM (LGBM), CatBoost, XGBoost, decision trees (DT), random forests (RF), and multinomial naive Bayes (MultinomialNB). This rigorous examination illuminates a distinguished model, achieving a remarkable accuracy rate of 99.683% on the LC25000 dataset. The extension of this methodology to breast cancer detection, utilizing the BreakHis dataset, yields a commendable accuracy rate of 94.808%. These findings underscore the transformative potential of AI in the intricate landscape of histopathological analysis, positioning it as a pivotal force in advancing diagnostic capabilities. A meticulous comparative analysis not only underscores the merits but also elucidates the limitations of existing AI applications in medical imaging, thereby charting a roadmap for future refinements and clinical deployments. Consequently, continued research in AI within clinical settings is advocated, with the ultimate aim of fortifying early cancer diagnosis and subsequently enhancing patient outcomes through judicious therapeutic interventions.


  • Open Access

    LightGBM: A Leading Force in Breast Cancer Diagnosis Through Machine Learning and Image Processing

    by Bassam M. Kanber, Ahmad Al Smadi, Naglaa F. Noaman, Bo Liu, Shuiping Gou, Mutasem K. Alsmadi

    The early diagnosis of breast cancer (BC), a prominent global cause of mortality, necessitates the development of innovative diagnostic strategies. This study leverages machine learning (ML) and advanced image processing techniques to analyze histopathology images, thereby augmenting the capabilities for BC diagnosis. A robust feature extraction (FE) pipeline is developed, integrating techniques such as color histogram analysis, contour feature extraction, hu moments, and haralick texture features. Ten ML algorithms, including LightGBM (LGBM), CatBoost, and XGBoost, are systematically evaluated across varying magnifications of the BreakHis dataset to assess their diagnostic performance. The research introduces a novel approach by combining distinct FE techniques, enhancing the model’s ability to distinguish between benign and malignant tissues with exceptional accuracy. These integrated techniques significantly elevate BC diagnostic accuracy and reliability, holding the potential to positively impact patient outcomes and healthcare systems. Notably, the combination of the FE pipeline and LGBM achieves the highest accuracy, reported in two forms: before augmentation accuracies (0.9598 for 40×, 0.9516 for 100×, 0.9652 for 200×, 0.9535 for 400×, and 0.9570 for all magnifications combined) and after augmentation accuracies (0.9949 for 40×, 0.9870 for 100×, 0.9987 for 200×, and 0.9918 for 400×) for the classification of magnification histopathological images. Moreover, the study highlights the crucial role of augmentation in further refining classification accuracy. Extending its applicability, the proposed method is also successfully applied to the classification of lung colon cancer images (LC25000 dataset), achieving an impressive accuracy of 0.9983. The model demonstrates its effectiveness and adaptability as a compelling method for histopathological image classification. This research contributes to the evolving field of BC diagnostics, offering a framework for robust and accurate ML-based diagnostic tools that may revolutionize cancer diagnosis and enhance patient care.